Charles River Laboratories CRL Debt issued (Note 13)
Debt issued (Note 13) at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfLongTermDebt.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's debt issued (note 13).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's debt issued (note 13)?
- Charles River Laboratories (CRL) reported debt issued (note 13) of $912.46M in Q1 2026.
- How has Charles River Laboratories's debt issued (note 13) changed year-over-year?
- Charles River Laboratories's debt issued (note 13) increased by 119.2% year-over-year, from $416.34M to $912.46M.
- What is the long-term trend for Charles River Laboratories's debt issued (note 13)?
- Over 4 years (2021 to 2025), Charles River Laboratories's debt issued (note 13) has grown at a -35.2% compound annual growth rate (CAGR), from $6.95B to $1.23B.
- What does debt issued (note 13) mean?
- Cash raised by borrowing money through long-term debt.
- How do you interpret debt issued (note 13)?
- Higher proceeds indicate increased leverage or refinancing activity, while lower proceeds suggest a reliance on internal cash or reduced debt appetite.
- How does debt issued (note 13) compare across companies?
- Standard line item in the financing section of the cash flow statement.